Skip to main content
Equibles

UBS Group AG

Position in BMY — Bristol Myers Squibb Co

CIK 1610520 ZURICH, V8
Back to BMY Full portfolio

Position in BMY

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$511,460,413
+$74,753,183 QoQ
Shares Held
8,876,439
+23.3% QoQ
Ownership
0.435%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#34
of 2,514 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 63% Shared 0% None 37%

Common Shares in BMY Over Time

Shares Held

Position Value (USD)

Derivatives in BMY

reported options exposure · as of Jun 30, 2026
CallValue
$9,812,686
CallShares
170,300
PutValue
$34,024,610
PutShares
590,500

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

UBS Group AG holds $17,056,271,930 across 20 Drug Manufacturers - General names. BMY ranks #8 (3.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 LLY
ELI LILLY & Co
 3,865,931 $4,636,914,000
2 ABBV
AbbVie Inc.
 12,845,120 $3,232,345,993
3 JNJ
Johnson & Johnson
 11,036,891 $2,803,039,201
4 MRK
Merck & Co., Inc.
 13,744,783 $1,766,204,613
5 AMGN
Amgen Inc
 3,308,695 $1,198,144,628
6 AZN
Astrazeneca PLC
 5,297,462 $1,004,504,738
7 GILD
Gilead Sciences, Inc.
 4,503,294 $568,946,162
8 BMY
Bristol Myers Squibb Co
This page 		8,876,439 $511,460,413

All Filings in BMY

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $9,812,686 170,300
2026-06-30 $511,460,413 8,876,439
2026-06-30 $34,024,610 590,500
2026-03-31 $13,100,400 216,000
2026-03-31 $436,707,230 7,200,449
2026-03-31 $18,395,145 303,300
2025-12-31 $90,651,186 1,680,593
2025-12-31 $331,790,979 6,151,112
2025-12-31 $47,488,776 880,400
2025-09-30 $10,950,505 242,805
2025-09-30 $65,913,334 1,461,493
2025-09-30 $480,619,784 10,656,758
2025-06-30 $8,404,180 181,555
2025-06-30 $573,333,540 12,385,689
2025-06-30 $25,325,259 547,100
2025-03-31 $20,315,769 333,100
2025-03-31 $587,481,353 9,632,421
2025-03-31 $32,734,979 536,727
2024-12-31 $37,529,087 663,527
2024-12-31 $71,695,456 1,267,600
2024-12-31 $543,779,602 9,614,208
2024-09-30 $34,011,133 657,347
2024-09-30 $48,526,946 937,900
2024-09-30 $394,852,098 7,631,467
2024-06-30 $272,160,995 6,553,359
2024-06-30 $6,081,113 146,427
2024-06-30 $26,670,566 642,200
2024-03-31 $16,346,386 301,427
2024-03-31 $413,071,698 7,617,033
2024-03-31 $29,132,356 537,200
2023-12-31 $249,973,391 4,871,826
2023-12-31 $90,977,761 1,773,100
2023-12-31 $107,032,660 2,086,000
2023-09-30 $92,742,116 1,597,900
2023-09-30 $110,287,608 1,900,200
2023-09-30 $401,639,990 6,920,055
2023-06-30 $393,696,598 6,156,319
2023-06-30 $66,597,530 1,041,400
2023-06-30 $106,291,295 1,662,100
2023-03-31 $127,301,677 1,836,700
2023-03-31 $86,893,947 1,253,700
2023-03-31 $414,853,478 5,985,478
2022-12-31 $491,001,979 6,824,211
2022-12-31 $200,157,705 2,781,900
2022-12-31 $91,304,550 1,269,000
2022-09-30 $38,921,775 547,500
2022-09-30 $130,727,401 1,838,900
2022-09-30 $388,467,038 5,464,440
2022-06-30 $128,366,700 1,667,100
2022-06-30 $453,753,608 5,892,904

Report a Problem

Category
Description
Email (optional, for follow-up)